During pharmaceutical development at Vivotecnia, we help the companies that trust in us to conduct preclinical, GLP-compliant general toxicology, genotoxicity, carcinogenicity, reproductive toxicity and safety pharmacology studies to evaluate the safety of new promising drugs. We work with different species of animals, from mice to dogs, depending on the type of study we are working on. This process adheres to international regulatory requirements and submission requirements for clinical trials or marketing authorization.
Vivotecnia’s extensive service catalog means we can offer you anything from stand-alone studies to complete first-in-human or full pharmaceutical-development study packages. Through the animal studies we offer, it may be possible to find drugs in the future that have not been used in humans to date.